DE60112117D1 - Warmgeformte feste arzneizusammensetzung zur gesteuerten wirkstoffabgabe von perindopril - Google Patents

Warmgeformte feste arzneizusammensetzung zur gesteuerten wirkstoffabgabe von perindopril

Info

Publication number
DE60112117D1
DE60112117D1 DE60112117T DE60112117T DE60112117D1 DE 60112117 D1 DE60112117 D1 DE 60112117D1 DE 60112117 T DE60112117 T DE 60112117T DE 60112117 T DE60112117 T DE 60112117T DE 60112117 D1 DE60112117 D1 DE 60112117D1
Authority
DE
Germany
Prior art keywords
perindopril
warm
formed solid
medicament composition
solid medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60112117T
Other languages
English (en)
Other versions
DE60112117T2 (de
Inventor
Patrick Wuthrich
Herve Rolland
Gilles Briault
Gerald Pichon
Francois Tharrault
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Servier SAS
Original Assignee
Laboratoires Servier SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Servier SAS filed Critical Laboratoires Servier SAS
Publication of DE60112117D1 publication Critical patent/DE60112117D1/de
Application granted granted Critical
Publication of DE60112117T2 publication Critical patent/DE60112117T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
DE60112117T 2000-12-26 2001-12-21 Warmgeformte feste arzneizusammensetzung zur gesteuerten wirkstoffabgabe von perindopril Expired - Lifetime DE60112117T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0017013 2000-12-26
FR0017013A FR2818550B1 (fr) 2000-12-26 2000-12-26 Composition pharmaceutique solide thermoformable pour la liberation controle de perindopril
PCT/FR2001/004133 WO2002051407A1 (fr) 2000-12-26 2001-12-21 Composition pharmaceutique solide thermoformable pour la liberation controlee de perindopril

Publications (2)

Publication Number Publication Date
DE60112117D1 true DE60112117D1 (de) 2005-08-25
DE60112117T2 DE60112117T2 (de) 2006-06-01

Family

ID=8858188

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60112117T Expired - Lifetime DE60112117T2 (de) 2000-12-26 2001-12-21 Warmgeformte feste arzneizusammensetzung zur gesteuerten wirkstoffabgabe von perindopril

Country Status (26)

Country Link
US (1) US20040115227A1 (de)
EP (1) EP1345605B1 (de)
JP (1) JP2004518666A (de)
KR (1) KR100542473B1 (de)
CN (1) CN1218696C (de)
AR (1) AR031972A1 (de)
AT (1) ATE299704T1 (de)
AU (1) AU2002228118B2 (de)
BR (1) BR0116536A (de)
CA (1) CA2432896A1 (de)
CZ (1) CZ297796B6 (de)
DE (1) DE60112117T2 (de)
DK (1) DK1345605T3 (de)
EA (1) EA005139B1 (de)
ES (1) ES2244672T3 (de)
FR (1) FR2818550B1 (de)
HK (1) HK1063739A1 (de)
HU (1) HU230249B1 (de)
MX (1) MXPA03005792A (de)
NO (1) NO333590B1 (de)
NZ (1) NZ526405A (de)
PL (1) PL203836B1 (de)
PT (1) PT1345605E (de)
SK (1) SK286920B6 (de)
WO (1) WO2002051407A1 (de)
ZA (1) ZA200304405B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK50252005A3 (sk) * 2005-03-22 2006-10-05 Vúlm, A.S. Farmaceutický prípravok obsahujúci perindopril erbumín, spôsob jeho prípravy a stabilizácie
BRPI0615607A2 (pt) * 2005-08-30 2011-05-24 Lek Pharmaceuticals composição farmacêutica compreendendo perindopril ou seus sais
BR112014004753A2 (pt) * 2011-08-30 2017-03-28 Univ Gent formulação de liberação de multicamadas
RU2670447C2 (ru) * 2016-11-17 2018-10-23 Общество с ограниченной ответственностью "Изварино Фарма" Пероральная твердая лекарственная форма с микофенольной кислотой или ее солью для использования в качестве иммунодепрессанта для лечения или предупреждения отторжения трансплантата органа или ткани и способ ее получения

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5002776A (en) * 1983-12-22 1991-03-26 Elan Corporation, Plc Controlled absorption diltiazem formulations
DE4138513A1 (de) * 1991-11-23 1993-05-27 Basf Ag Feste pharmazeutische retardform
US5589499A (en) * 1992-11-25 1996-12-31 Weth; Gosbert Dopaminergic agents for the treatment of cerebral and peripheral blood flow disorders
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
DE19724696A1 (de) * 1997-06-12 1998-12-24 Hexal Ag Pharmazeutische Zubereitung mit drei Pelletarten
GB9910773D0 (en) * 1999-05-11 1999-07-07 West Pharm Serv Drug Res Ltd Novel single unit coated dosage forms that can be used to minimise the effect of food on the absorption of drugs from the gastrointestinal tract
FR2795326B1 (fr) * 1999-06-28 2001-08-31 Adir Composition pharmaceutique solide thermoformable a liberation controlee

Also Published As

Publication number Publication date
KR20030064877A (ko) 2003-08-02
SK286920B6 (sk) 2009-07-06
DK1345605T3 (da) 2005-10-10
CN1218696C (zh) 2005-09-14
HU230249B1 (hu) 2015-11-30
EA005139B1 (ru) 2004-12-30
WO2002051407A1 (fr) 2002-07-04
HK1063739A1 (en) 2005-01-14
NZ526405A (en) 2004-12-24
PL361663A1 (en) 2004-10-04
CZ20032008A3 (cs) 2004-01-14
CZ297796B6 (cs) 2007-03-28
BR0116536A (pt) 2003-10-21
NO20032738L (no) 2003-06-16
ATE299704T1 (de) 2005-08-15
CA2432896A1 (fr) 2002-07-04
HUP0302524A3 (en) 2007-09-28
AU2002228118B2 (en) 2006-04-27
EP1345605A1 (de) 2003-09-24
NO333590B1 (no) 2013-07-15
FR2818550A1 (fr) 2002-06-28
AR031972A1 (es) 2003-10-08
US20040115227A1 (en) 2004-06-17
DE60112117T2 (de) 2006-06-01
NO20032738D0 (no) 2003-06-16
JP2004518666A (ja) 2004-06-24
FR2818550B1 (fr) 2003-02-07
MXPA03005792A (es) 2003-09-10
HUP0302524A2 (hu) 2003-12-29
PT1345605E (pt) 2005-11-30
ES2244672T3 (es) 2005-12-16
KR100542473B1 (ko) 2006-01-11
EP1345605B1 (de) 2005-07-20
SK9432003A3 (en) 2003-12-02
PL203836B1 (pl) 2009-11-30
ZA200304405B (en) 2004-06-25
EA200300664A1 (ru) 2003-12-25
CN1482909A (zh) 2004-03-17

Similar Documents

Publication Publication Date Title
DE60220661D1 (de) Transdermales pflaster zur verabreichung von fentanyl
DK2412368T3 (da) Sammensætning til behandling af ar
NO20006630L (no) Farmasöytisk sammensetning for behandlingen av diabetes
DE50206657D1 (de) Pharmazeutische zusammensetzung zur behandlung von multiple sklerose
FI991485A0 (fi) Uusi farmaseuttinen koostumus
NO20015175L (no) Farmasöytisk sammensetning
DK1147083T3 (da) Arylpiperazinyl-cyclohexylindolderivater til behandling af depression
DE69942928D1 (de) Therapeutische formulierung zur verabreichung von tolterodin mit kontrollierter freisetzung
ATE254920T1 (de) Neue galenische zubereitungsformen von meloxicam zur oralen applikation
AU1531502A (en) Composition for the transdermal delivery of fentanyl
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
ATE447947T1 (de) Pharmazeutische zubereitungen zur behandlung von insulinresitenz
EE05020B1 (et) Glburiidi ravimkoostis
DE60042550D1 (de) Mutierte varianten des insulin-ähnlichen wachstumsfaktor i (igf-i)
DE60126321D1 (de) Gelsystem zur ocularen verabreichung von arzneimitteln
DE60126838D1 (de) Amidoacetonitrile zur Bekämpfung von Endoparasiten
DE60103889D1 (de) Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamidderivate zur schmerzbekämpfung
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
DE60136909D1 (de) Arzneimittel mit anemonin als aktivum zur behandlung von aseptischer inflammation
ATE295174T1 (de) Arzneimittel zur behandlung von bluthochdruck
TR199903132A3 (tr) Metalosan bilesiklerinin aktive edici kompozisyonu.
DK1150681T3 (da) Anvendelse af en farmaceutisk sammensætning indeholdende desoxypeganin til behandling af nikotinafhængighed
PT1227817E (pt) Composicao farmaceutica aquosa contendo ciclesonida
FI4488U1 (fi) Farmaseuttinen koostumus
DE60112117D1 (de) Warmgeformte feste arzneizusammensetzung zur gesteuerten wirkstoffabgabe von perindopril

Legal Events

Date Code Title Description
8364 No opposition during term of opposition